Oncology Today with Dr Neil Love cover image

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Oncology Today with Dr Neil Love

00:00

Choosing Second-line Therapy After CDK4/6

Joyce and Rinath debate options after CDK4/6 progression, favoring oral SERDs for indolent disease and combinations for visceral disease.

Play episode from 11:10
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app